| Project/Area Number |
01570633
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
内分泌・代謝学
|
|---|
| Research Institution | Nagoya University |
|---|
Principal Investigator |
OISO Yutaka Nagoya University School of Medicine assistant, 医学部, 助手 (40203707)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ITO Masahumi Nagoya University School of Medicine medical staff, 医学部, 医員
大竹 千生 名古屋大学, 医学部, 医員
|
|---|
| Project Period (FY) |
1989 – 1990
|
| Project Status |
Completed (Fiscal Year 1990)
|
| Budget Amount *help |
¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1990: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1989: ¥1,000,000 (Direct Cost: ¥1,000,000)
|
|---|
| Keywords | Vasopressin / Opioid peptides / Gamma-aminobutyric acid / パゾプレシン / 分泌制御 / 容量受容体 / 延髓孤束核 / オピオイド受容体サブクラス |
|---|
| Research Abstract |
1. The role of opioid kappa-, mu- and delta-receptor in the secretion of arginine vasopressin (AVP) was first studied. Opioid kappa- and mu- receptor agonists significantly suppressed plasma AVP increased by hyperosmolar or hypovolemic stimulation. Opioid delta-receptor agonist did not suppressed plasma AVP induced by hypovolemia. These results suggest that suppressive activity of opioid receptor agonist for AVP secretion depends on its biological subclass.
2. Secondly, we examined the effect of gamma-aminobutyric acid (GABA) and naloxone, a potent opioid antagonist, on AVP secretion in conscious rats in order to study the relationship of GABA and endogenous opioid peptides in the regulation of AVP secretion. Intracerebroventricular administration of GABA caused a time and dose dependent decrease in the plasma concentration of AVP that was elevated by hypertonic saline injection, whereas it did not affect the basal AVP. Pretreatment with naloxone significantly attenuated the inhibitory effect of GABA on AVP release. These results suggest that GABA produces an inhibition of AVP release stimulated by hypertonic saline, and that this inhibitory effect may be mediated at least in part by the endogenous opioid systems.
|
